Journal of the American Heart Association

DECEMBER 24, 2024

BackgroundThis realworld evidence study compared risks of cardiovascular events in hospital settings among patients with chronic kidney disease (CKD) with and without hyperkalemia.Methods and ResultsAdults with CKD stages 3b/4 with and without hyperkalemia were identified from Optum's deidentified Market Clarity Data (January 2016August 2022).

Kidney Disease 45

Kidney Disease Arrhythmia Myocardial Infarction Atrial Fibrillation 45

European Journal of Heart Failure

JANUARY 17, 2025

Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by diuretic use: a FIDELITY analysis. a If patients were receiving both types of diuretics at baseline, they were included in both subgroups. Patients were analysed by baseline diuretic use (yes/no) and type of diuretic (loop or thiazide).

Kidney Disease 40

Kidney Disease Diabetes Myocardial Infarction Heart Failure 40

Circulation

NOVEMBER 11, 2024

Background:Empagliflozin is a sodium glucose co-transporter 2 inhibitor that improves cardiovascular outcomes in patients with type 2 diabetes mellitus, chronic kidney disease and heart failure. Circulation, Volume 150, Issue Suppl_1 , Page A4121215-A4121215, November 12, 2024.

Myocardial Infarction 40

Myocardial Infarction Blood Pressure Heart Failure Kidney Disease 40

European Journal of Heart Failure

DECEMBER 12, 2023

Abstract Objectives This study aimed to assess the impact of anemia and iron deficiency (ID) on clinical outcome in patients with cardiogenic shock (CS) complicating acute myocardial infarction (AMI).

Cardiogenic Shock 40

Cardiogenic Shock Myocardial Infarction Outcomes Catheterization Laboratory 40

DAIC

APRIL 6, 2024

As evidence has mounted pointing to their benefits in reducing heart failure and other forms of heart disease, researchers have sought to determine whether these drugs could help to prevent heart failure even in people without diabetes or chronic kidney disease. ET / 14:45 UTC in Room B203.

Heart attacks 98

Heart attacks Heart Attack Heart Failure Outpatient 98

Dr. Smith's ECG Blog

SEPTEMBER 5, 2024

This is a value typical for a large subacute MI, n ormal value 48 hours after myocardial infarction is associated with Post-Infarction Regional Pericarditis ( PIRP ). Mechanical complications secondary to myocardial infarction are infrequent due to most patients receiving revascularization quite rapidly.

Cardiogenic Shock 109

Cardiogenic Shock Chest Pain Pericarditis Myocardial Infarction 109

DAIC

SEPTEMBER 11, 2024

The study appears Sept. 11 in the Journal of the American College of Cardiology JACC.

Atrial Fibrillation 92

Atrial Fibrillation Quality of Life Myocardial Infarction Kidney Disease 92

DAIC

APRIL 6, 2024

As evidence has mounted pointing to their benefits in reducing heart failure and other forms of heart disease, researchers have sought to determine whether these drugs could help to prevent heart failure even in people without diabetes or chronic kidney disease. 24 conference.

Heart attacks 81

Heart attacks Heart Attack Heart Failure Outcomes 81

Journal of the American Heart Association

MARCH 21, 2025

Study end points include mortality, cardiovascular events (hospitalization for acute myocardial infarction or stroke) and limb events (hospitalization for critical limb ischemia or major amputation) and were identified using Veterans Affairs and nonVeterans Affairs encounters.ResultsThe mean age was 70.6 were male, and 18.5%

Peripheral Arterial Disease 45

Peripheral Arterial Disease Outcomes Myocardial Infarction Kidney Disease 45

Frontiers in Cardiovascular Medicine

JULY 28, 2024

Myocardial infarction (MI) has been traditionally regarded as the main cause of MC overall; however, no updated comprehensive data on the relative incidence of different forms of MC is available. The majority of patients (69.8%) presented with dystrophic MC.

Myocardial Infarction 52

Myocardial Infarction Kidney Disease Heart Disease 52

Open Heart

JULY 10, 2023

Higher-predicted risk, compared with lower-predicted risk, was associated with incident chronic kidney disease (cumulative incidence per 1000 persons at 10 years 245.2; to 8.34; 4.27), myocardial infarction (69.6; to 5.22; 4.32), peripheral vascular disease (44.6; to 6.98; 4.28), valvular heart disease (37.8;

Atrial Fibrillation 52

Atrial Fibrillation Myocardial Infarction Kidney Disease Innovation 52

Circulation

NOVEMBER 11, 2024

The secondary outcomes comprise the odds of adverse events, including myocardial infarction, ischemic stroke, transient ischemic attack (TIA), occlusive atherosclerotic disease, percutaneous coronary intervention, and coronary artery bypass graft (CABG)., The hemophilia cohort was slightly older (63.2[16.8]

Risk Factors 40

Risk Factors Cardiovascular Disease Coronary Artery Bypass Graft Outcomes 40

Circulation: Heart Failure

NOVEMBER 25, 2024

Spironolactone improved outcomes in patients with severely symptomatic HF with reduced ejection fraction, and later, eplerenone expanded the benefits to patients with mildly symptomatic HF with reduced ejection fraction and myocardial infarction complicated by HF.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Heart Failure Myocardial Infarction Kidney Disease 40

Journal of Cardiovascular Pharmacology

OCTOBER 9, 2024

Patients in the combination AP +AC therapy group had a higher prevalence of CAD, myocardial infarction, and coronary/vascular stent placement compared to the AC monotherapy group. The median follow-up of patients was 57 months. The median follow-up of patients was 57 months.

Atrial Fibrillation 40

Atrial Fibrillation Myocardial Infarction Kidney Disease Stents 40

Journal of the American Heart Association

JANUARY 9, 2024

615 patients, the 186 (30.2%) patients with protruding aortic plaque were older and had more comorbidities such as hypertension, chronic kidney disease, and a prior myocardial infarction than those without.

Plaque 45

Plaque Aortic Myocardial Infarction Kidney Disease 45

Journal of the American Heart Association

FEBRUARY 16, 2024

Fifteen parameters were selected to assess in‐hospital mortality. The developed model was validated internally and externally using an independent external cohort (n=138). The developed model was validated internally and externally using an independent external cohort (n=138). Among 322 patients, 138 (42.9%) survived postdischarge.

Cardiogenic Shock 45

Cardiogenic Shock Hospital Myocardial Infarction Kidney Disease 45

Dr. Smith's ECG Blog

APRIL 8, 2016

He also had a history of chronic kidney disease, stage III. Angio had shown some acute disease in the saphenous vein graft to the posterior descending artery off of the RCA. Literature on Hypokalemia as a risk for ventricular fibrillation in acute myocardial infarction. Most recent echo showed EF of 60%.

STEMI 52

STEMI Myocardial Infarction Cardiac Arrest Arrhythmia 52

Circulation

NOVEMBER 11, 2024

The relationship between salvage index and myocardial blush grade was shown in figure 2. Methods:STEMI patients who underwent coronary revascularization therapy and cardiac magnetic resonance (CMR) at about 4 days and 6 months between 2017 and 2023 were included. The relationship between salvage index and FSF was shown in figure1.

STEMI 40

STEMI Myocardial Infarction Kidney Disease Thrombolysis 40

Stroke Journal

JANUARY 30, 2025

Background:The ABCD-GENE score, incorporating age, body mass index, chronic kidney disease, diabetes, and CYP2C19 genotypes, is a validated risk score that integrates clinical risk factors with genetic information to predict clopidogrel response. Stroke, Volume 56, Issue Suppl_1 , Page AWP289-AWP289, February 1, 2025.

Diabetes 40

Diabetes Stroke Strokes Myocardial Infarction 40

Circulation

NOVEMBER 11, 2024

Background:The Trial to Evaluate Cardiovascular and Other Long-term Outcomes with Semaglutide in Subjects with Type 2 Diabetes (SUSTAIN-6) trial showed cardiovascular disease (CVD) benefits of semaglutide therapy in patients with type 2 diabetes mellitus (T2DM).Purpose:To year follow-up time).Results:Among Results:Among 5002 (projected to 34.0

Diabetes 40

Diabetes Blood Pressure Myocardial Infarction Kidney Disease 40

DAIC

SEPTEMBER 11, 2024

The study appears Sept. 11 in the Journal of the American College of Cardiology JACC.

Atrial Fibrillation 52

Atrial Fibrillation Quality of Life Myocardial Infarction Kidney Disease 52

Circulation: Cardiovascular Imaging

JANUARY 15, 2024

BACKGROUND:Advanced chronic kidney disease is associated with high cardiovascular risk, even after kidney transplant. METHODS:We retrospectively followed patients who underwent MPI before kidney transplant for the occurrence of MACE after transplant including myocardial infarction, stroke, heart failure, and cardiac death.

Transplant 40

Transplant Coronary Artery Disease Myocardial Infarction Kidney Disease 40

Stroke Journal

JANUARY 30, 2025

Propensity score-matched analysis (PSM) (1:1) was performed with matching for age, gender, race, BMI, hypertension, diabetes mellitus, chronic kidney disease, hemoglobin level, low-density lipid (LDL) level, left ventricular ejection fraction, and various drugs including ACEi, ARBi, ARNI, beta-blockers, and diuretics.

Outcomes 40

Outcomes Atrial Fibrillation Heart Failure Tachycardia 40

European Journal of Heart Failure

JANUARY 20, 2025

Recursive feature elimination was employed to identify the most relevant features in predicting the risk of mortality. Abstract Aims Accurate selection of patients with severe heart failure (HF) who might benefit from advanced therapies is crucial.

Heart Failure 40

Heart Failure Coronary Artery Disease Myocardial Infarction Kidney Disease 40

DAIC

JANUARY 23, 2024

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3

Cardiovascular Disease 111

Cardiovascular Disease Heart attacks Heart Attack Coronary Artery Disease 111

Cardiometabolic Health Congress

JULY 25, 2023

17] Glycemic improvement alone, however, has not been associated with improved risk of macrovascular diabetes complications, such as myocardial infarction, stroke and heart failure.

Obesity 52

Obesity BMI Heart Failure Cardiovascular Disease 52

Cardiometabolic Health Congress

DECEMBER 7, 2023

AF is associated with an increased risk of death as well as multiple adverse outcomes, including stroke, cognitive impairment or dementia, myocardial infarction, sudden cardiac death, heart failure (HF), chronic kidney disease (CKD), and peripheral artery disease (PAD).

Atrial Fibrillation 111

Atrial Fibrillation Risk Factors Ablation Stroke 111

Open Heart

JANUARY 13, 2023

Clinical experts preselected sex, age at HF, NewYork Heart Association (NYHA) class, hypertension, diabetes mellitus, chronic kidney disease, obstructive sleep apnoea, chronic obstructive pulmonary disease and myocardial infarction. to 11.8%) for males and 6.4% (95% CI 4.9% to 8.4%) and 5.1% (95% CI 4.5%

Atrial Fibrillation 52

Atrial Fibrillation Heart Failure Myocardial Infarction Kidney Disease 52

Circulation

NOVEMBER 11, 2024

Out of 26 patients with congenital heart disease, a majority had a diagnosis of tetralogy of Fallot (57.6%) and 69% had 2-3 prior open-heart surgeries, including ventriculotomy (53.8%), ventricular septal defect repair (65.3%), and pulmonary valve replacement (57.6%) (Table2).

Congenital Heart Disease 40

Congenital Heart Disease Congenital Tachycardia Heart Disease 40

Circulation

NOVEMBER 11, 2024

Predictors of high-risk of advanced liver fibrosis, included older age, male sex, severe chronic kidney disease, previous myocardial infarction, ischemic heart disease, and atrial fibrillation/flutter. High-risk of advanced liver fibrosis was highly prevalent, affecting 30% of the studied population.

Heart Failure 40

Heart Failure Diabetes Myocardial Infarction Kidney Disease 40

Circulation

NOVEMBER 16, 2023

2.57]), chronic kidney disease (adjusted HR, 1.68 [95% CI, 1.36–2.09]), 1.95]), myocardial infarction (adjusted HR, 1.41 [95% CI, 1.05–1.90]), Clinical factors associated with higher mortality included male sex (adjusted HR, 1.31 [95% CI, 1.08–1.58]), 1.58]), older age (adjusted HR, 1.19 per 5-year increase [95% CI, 1.15–1.23]),

Cholesterol 40

Cholesterol Myocardial Infarction Kidney Disease Heart Failure 40

Frontiers in Cardiovascular Medicine

DECEMBER 18, 2024

BackgroundInflammation significantly impacts chronic kidney disease (CKD) and acute myocardial infarction (AMI).

Myocardial Infarction 52

Myocardial Infarction Kidney Disease Risk Factors Hospital 52

Frontiers in Cardiovascular Medicine

FEBRUARY 20, 2025

BackgroundPatients with both acute coronary syndrome (ACS) and chronic kidney disease (CKD) face heightened risks of adverse cardiovascular events and bleeding. No significant differences were observed in all-cause mortality, major bleeding, cardiovascular death, or acute myocardial infarction.

Kidney Disease 52

Kidney Disease Myocardial Infarction Outcomes Stroke 52

Cardiometabolic Health Congress

NOVEMBER 14, 2024

Additionally, 10% of the global population suffers from chronic kidney disease , with diabetes and hypertension as significant risk factors. Disparities in care are also concerning, with diagnosed cardiometabolic diseases varying up to twofold among different racial and ethnic groups. In the U.S.,

CME 103

CME Obesity Heart Failure Biomarkers 103

Frontiers in Cardiovascular Medicine

NOVEMBER 21, 2024

The eGFR estimates were calculated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation. CVD was defined as a self-reported physician's diagnosis of congestive heart failure, coronary heart disease, angina pectoris, myocardial infarction, or stroke. ml/min/1.73 m².

Cardiovascular Disease 52

Cardiovascular Disease Myocardial Infarction Kidney Disease Angina 52

Dr. Smith's ECG Blog

FEBRUARY 26, 2025

It could also, given a different clinical context be compatible with a subacute myocardial infarction complicated by post infarct regional pericarditis. Most common cause) 2 ) Post infarct regional pericarditis. Due to the atypical and vague symptoms, the myocardial infarct was not initially diagnosed.

Chest Pain 89

Chest Pain Pericarditis Myocardial Infarction Dementia 89